Biomarkers for preclinical Alzheimer's disease:
This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer's disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
New York, NY
Springer New York
2018
|
Ausgabe: | 1st ed. 2018 |
Schriftenreihe: | Neuromethods
137 |
Schlagworte: | |
Online-Zugang: | UBR01 TUM01 Volltext |
Zusammenfassung: | This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer's disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Comprehensive and cutting-edge, Biomarkers for Preclinical Alzheimer's Disease is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry |
Beschreibung: | 1 Online-Ressource (XIII, 272 Seiten) Illustrationen |
ISBN: | 9781493976744 |
DOI: | 10.1007/978-1-4939-7674-4 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV047613423 | ||
003 | DE-604 | ||
005 | 20211129 | ||
007 | cr|uuu---uuuuu | ||
008 | 211126s2018 |||| o||u| ||||||eng d | ||
020 | |a 9781493976744 |c Online |9 978-1-4939-7674-4 | ||
024 | 7 | |a 10.1007/978-1-4939-7674-4 |2 doi | |
035 | |a (ZDB-2-PRO)978-1-4939-7674-4 | ||
035 | |a (OCoLC)1286874315 | ||
035 | |a (DE-599)BVBBV047613423 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-91 | ||
082 | 0 | |a 612.8 | |
245 | 1 | 0 | |a Biomarkers for preclinical Alzheimer's disease |c edited by Robert Perneczky |
250 | |a 1st ed. 2018 | ||
264 | 1 | |a New York, NY |b Springer New York |c 2018 | |
300 | |a 1 Online-Ressource (XIII, 272 Seiten) |b Illustrationen | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Neuromethods | |
490 | 0 | |a 137 | |
520 | |a This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer's disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Comprehensive and cutting-edge, Biomarkers for Preclinical Alzheimer's Disease is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry | ||
650 | 4 | |a Neurosciences | |
650 | 0 | 7 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Biomarker |0 (DE-588)4425928-1 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |D s |
689 | 0 | 1 | |a Biomarker |0 (DE-588)4425928-1 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Perneczky, Robert |d 1975- |0 (DE-588)129318663 |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-4939-7673-7 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-4939-7675-1 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-4939-9255-3 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4939-7674-4 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-PRO | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-032998202 | ||
966 | e | |u https://doi.org/10.1007/978-1-4939-7674-4 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1007/978-1-4939-7674-4 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804182982456508416 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author2 | Perneczky, Robert 1975- |
author2_role | edt |
author2_variant | r p rp |
author_GND | (DE-588)129318663 |
author_facet | Perneczky, Robert 1975- |
building | Verbundindex |
bvnumber | BV047613423 |
collection | ZDB-2-PRO |
ctrlnum | (ZDB-2-PRO)978-1-4939-7674-4 (OCoLC)1286874315 (DE-599)BVBBV047613423 |
dewey-full | 612.8 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 612 - Human physiology |
dewey-raw | 612.8 |
dewey-search | 612.8 |
dewey-sort | 3612.8 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
discipline_str_mv | Medizin |
doi_str_mv | 10.1007/978-1-4939-7674-4 |
edition | 1st ed. 2018 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03008nmm a2200505zc 4500</leader><controlfield tag="001">BV047613423</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20211129 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">211126s2018 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781493976744</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4939-7674-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4939-7674-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-4939-7674-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1286874315</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047613423</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">612.8</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biomarkers for preclinical Alzheimer's disease</subfield><subfield code="c">edited by Robert Perneczky</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2018</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer New York</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIII, 272 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Neuromethods</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">137</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer's disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Comprehensive and cutting-edge, Biomarkers for Preclinical Alzheimer's Disease is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurosciences</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biomarker</subfield><subfield code="0">(DE-588)4425928-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Biomarker</subfield><subfield code="0">(DE-588)4425928-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perneczky, Robert</subfield><subfield code="d">1975-</subfield><subfield code="0">(DE-588)129318663</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-4939-7673-7</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-4939-7675-1</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-4939-9255-3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4939-7674-4</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032998202</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-7674-4</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-7674-4</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV047613423 |
illustrated | Not Illustrated |
index_date | 2024-07-03T18:40:34Z |
indexdate | 2024-07-10T09:16:12Z |
institution | BVB |
isbn | 9781493976744 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032998202 |
oclc_num | 1286874315 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (XIII, 272 Seiten) Illustrationen |
psigel | ZDB-2-PRO |
publishDate | 2018 |
publishDateSearch | 2018 |
publishDateSort | 2018 |
publisher | Springer New York |
record_format | marc |
series2 | Neuromethods 137 |
spelling | Biomarkers for preclinical Alzheimer's disease edited by Robert Perneczky 1st ed. 2018 New York, NY Springer New York 2018 1 Online-Ressource (XIII, 272 Seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier Neuromethods 137 This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer's disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Comprehensive and cutting-edge, Biomarkers for Preclinical Alzheimer's Disease is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry Neurosciences Alzheimerkrankheit (DE-588)4112510-1 gnd rswk-swf Biomarker (DE-588)4425928-1 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Alzheimerkrankheit (DE-588)4112510-1 s Biomarker (DE-588)4425928-1 s DE-604 Perneczky, Robert 1975- (DE-588)129318663 edt Erscheint auch als Druck-Ausgabe 978-1-4939-7673-7 Erscheint auch als Druck-Ausgabe 978-1-4939-7675-1 Erscheint auch als Druck-Ausgabe 978-1-4939-9255-3 https://doi.org/10.1007/978-1-4939-7674-4 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Biomarkers for preclinical Alzheimer's disease Neurosciences Alzheimerkrankheit (DE-588)4112510-1 gnd Biomarker (DE-588)4425928-1 gnd |
subject_GND | (DE-588)4112510-1 (DE-588)4425928-1 (DE-588)4143413-4 |
title | Biomarkers for preclinical Alzheimer's disease |
title_auth | Biomarkers for preclinical Alzheimer's disease |
title_exact_search | Biomarkers for preclinical Alzheimer's disease |
title_exact_search_txtP | Biomarkers for preclinical Alzheimer's disease |
title_full | Biomarkers for preclinical Alzheimer's disease edited by Robert Perneczky |
title_fullStr | Biomarkers for preclinical Alzheimer's disease edited by Robert Perneczky |
title_full_unstemmed | Biomarkers for preclinical Alzheimer's disease edited by Robert Perneczky |
title_short | Biomarkers for preclinical Alzheimer's disease |
title_sort | biomarkers for preclinical alzheimer s disease |
topic | Neurosciences Alzheimerkrankheit (DE-588)4112510-1 gnd Biomarker (DE-588)4425928-1 gnd |
topic_facet | Neurosciences Alzheimerkrankheit Biomarker Aufsatzsammlung |
url | https://doi.org/10.1007/978-1-4939-7674-4 |
work_keys_str_mv | AT perneczkyrobert biomarkersforpreclinicalalzheimersdisease |